Overview

This study presents a standardized and partially automated protocol for the extraction of high-quality nuclei from frozen mammalian tissues, aiming to enhance the efficacy and reliability of downstream single nuclei RNA sequencing. The protocol serves to improve drug discovery studies by reducing non-biological variability.

Key Study Components

Research Area

Single nuclei RNA sequencing
Drug discovery studies
High-quality nuclei isolation

Background

Development of standardized nuclei extraction protocols
Focus on fresh frozen tissue samples from various organs
Aim to address drug biodistribution and safety signals

Methods Used

Partially automated nuclei extraction using a robotic dissociator
Mammalian tissues from various species
Implementation of sucrose gradient cleanup

Main Results

High-quality nuclei obtained without signs of debris or clumping
Consistent results across different tissue types
Low technical variability and similar cellular proportions across samples

Conclusions

The study successfully automates and standardizes nuclei extraction.
This protocol can significantly aid in answering biological questions in drug discovery and safety assessments.

Frequently Asked Questions

What is the main goal of the study?

The main goal is to develop a standardized protocol for nuclei extraction to improve drug discovery studies.

How does the protocol reduce variability?

By partially automating the extraction process, the protocol minimizes non-biological variability.

What types of tissues can be used?

The protocol can be applied to various fresh frozen mammalian tissues.

What downstream applications are anticipated for this protocol?

Future applications may include ATAC-seq and multiomics projects.

How was the quality of the isolated nuclei assessed?

The quality was assessed by analyzing gene counts, UMI counts, and mitochondrial content in the samples.

What technology is used for nuclei extraction?

A robotic dissociator is used for the nuclei extraction process.

What research area does this protocol support?

This protocol supports research in drug discovery and cellular mechanisms.

Institution - Roche Innovation Centre Basel

Articles Published in JoVE